Globe Life Inc. (GL) Stock Price & How to Invest

Globe Life Inc. is a Texas-based insurance holding company (formerly Torchmark) that underwrites individual life insurance and supplemental health insurance aimed at lower-to-middle-income American families. It sells through captive and exclusive agency channels under subsidiaries including American Income Life, Liberty National, Family Heritage, United American, and the direct-to-consumer Globe Life brand, and reports across life, health, and investment segments. The model emphasizes a large in-force book of small-face-amount policies with high persistency, which produces recurring premium and a sizable investment portfolio.

The investment picture centers on consistent premium growth, mid-to-high-teens return on equity, and aggressive share repurchases that compound book value per share. Recent results show revenue and operating earnings growing at mid-single-digit to low-double-digit rates, and management raised full-year 2026 earnings guidance. The main counterweight is reputational and legal: in April 2024 short-seller Fuzzy Panda alleged widespread insurance fraud tied to agents at American Income Life, which halved the stock, and while the US Attorney's Office closed its investigation in mid-2025 without enforcement action, shareholder litigation and ongoing scrutiny of the agency distribution model remain part of the story.

Reputational and legal exposure is the defining risk: the 2024 Fuzzy Panda short report alleged systemic insurance fraud (policies for deceased or fictitious people, forged signatures, unauthorized withdrawals) concentrated in agents at American Income Life, and shareholder and derivative lawsuits alleging the company misled investors remain ongoing even after the DOJ probe closed without action. The captive and exclusive agency distribution model concentrates sales in third-party agencies whose conduct the company must police, creating continued regulatory and headline risk. As a life and health insurer, GL is also exposed to interest-rate and credit risk on its large investment portfolio, mortality and morbidity experience, and reserve-adequacy assumptions. Any renewed regulatory inquiry or adverse litigation outcome could pressure the stock, and the middle-income customer base can be sensitive to economic stress and policy lapse.

11 analysts publish price targets on GL, averaging $193.91 against a $182.25 price as of August 2026, or +6.4%. The published targets run from $166.00 to $225.00, a moderate spread, and the ratings split 8 buy, 3 hold, 0 sell. Over the last six months there have been 11 raises and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full GL forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Globe Life Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Premium growth across agency divisions. Life and health premium continue to grow, with American Income Life and Liberty National posting net sales gains and rising underwriting margins in recent quarters. The most optimistic published target, $225.00, assumes this works close to its best case.

The case against. Reputational and legal exposure is the defining risk: the 2024 Fuzzy Panda short report alleged systemic insurance fraud (policies for deceased or fictitious people, forged signatures, unauthorized withdrawals) concentrated in agents at American Income Life, and shareholder and derivative lawsuits alleging the company misled investors remain ongoing even after the DOJ probe closed without action. The most pessimistic target, $166.00, is roughly what GL is worth if this bites instead.

Read the full bull and bear case on GL, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Globe Life Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$6.0B
• Market cap: ~$13.9B
• Diluted EPS (2025): ~$14.07
• 2026 EPS guidance: ~$15.40 to $15.90
• Trailing P/E: ~11x
• Dividend yield: ~0.9%

GL trades at a low-teens trailing price-to-earnings multiple, well below the broad market, reflecting both its steady insurance-underwriting profile and the reputational discount lingering from the 2024 allegations. Return on equity in the high teens and book value per share near $77 support a valuation that leans on consistent earnings and buybacks rather than high growth. Figures are approximate and drawn from 2025 results and 2026 quarterly reporting.

Other names that sit close to GL: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get GL exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so GL sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where GL fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

GL is a profitable, dividend-growing life and health insurer with strong book-value compounding, weighed against lingering legal and reputational scrutiny tied to its agency distribution model.

Whether GL is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is GL a buy or a sell?, and where the stock could go from here in the GL stock forecast.

For income investors, whether GL pays a dividend and how the payout looks is covered in does GL pay a dividend? And to weigh GL against a peer, read the full side-by-side comparisons: GL vs PRI and GL vs AFL.